Cancer outcomes in patients eligible for adjuvant cyclin-dependent kinase 4 and 6 inhibitors but spared adjuvant chemotherapy by Oncotype Dx: A multicenter retrospective GBECAM 0520 study.
Oliveira LJC, Rosa DD, Katz A, Assad-Suzuki D, Argolo D, Sanches SM, Testa L, Bines J, Kaliks RA, de Melo Gagliato D, Barroso-Sousa R, Corrêa TS, Shimada AK, Dos Anjos CH, Linck R, Megid TBC, Batista DN, Gomes DM, Cesca MG, Gaudêncio D, Moura LMA, Pereira de Araújo JA, Bonadio RC, Silva de Souza Z, Beal JR, Lopes MM, Sales LT, Parisi Marlière JLF, Mano MS.
Oliveira LJC, et al. Among authors: megid tbc.
Breast. 2025 Oct;83:104554. doi: 10.1016/j.breast.2025.104554. Epub 2025 Aug 5.
Breast. 2025.
PMID: 40768821
Free PMC article.